Cargando…
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic
Microbial secondary infections can contribute to an increase in the risk of mortality in COVID-19 patients, particularly in case of severe diseases. In this study, we collected and evaluated the clinical, laboratory and microbiological data of COVID-19 critical ill patients requiring intensive care...
Autores principales: | Murgia, Federica, Fiamma, Maura, Serra, Silvia, Marras, Giulia, Argiolas, Raul, Mattana, Chiara, Mattu, Maria Grazia, Garau, Maria Cristina, Doneddu, Sonia, Olla, Sabrina, Cocco, Eleonora, Lorefice, Lorena, Muntoni, Sandro, Paffi, Peppino, Porru, Stefano, Abis, Marta, Bellizzi, Saverio, Pani, Antonello, Angioi, Andrea, Simbula, Gabriella, Mussap, Michele, Massidda, Orietta, Carta, Franco, Atzori, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717567/ https://www.ncbi.nlm.nih.gov/pubmed/36459278 http://dx.doi.org/10.1007/s10238-022-00959-1 |
Ejemplares similares
-
The impact of secondary infections in COVID-19 critically ill patients
por: Murgia, Federica, et al.
Publicado: (2022) -
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
por: Lorefice, Lorena, et al.
Publicado: (2023) -
Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis
por: Murgia, Federica, et al.
Publicado: (2020) -
Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod
por: Murgia, Federica, et al.
Publicado: (2023) -
Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements
por: Lorefice, Lorena, et al.
Publicado: (2023)